![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-26-2024-3489.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208896
https://www.contractpharma.com/contents/view_breaking-news/2024-06-24/lupin-appoints-abdelaziz-toumi-as-ceo-of-its-api-cdmo-subsidiary/9769
https://www.indianpharmapost.com/news/lupin-and-fuji-sign-agreement-for-commercialization-of-nextstellis-in-vietnam-and-philippines-15778
https://www.biospectrumasia.com/news/26/24434/thailand-announces-investment-worth-1-54-b-in-biochemicals-data-centres-and-hospital.html
https://www.indianpharmapost.com/drug-approval/usfda-inspection-of-lupins-nagpur-injectable-facility-with-zero-483-observations-15766
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-22-2024-28085.pdf
https://www.business-standard.com/markets/capital-market-news/lupin-s-usa-facility-gets-6-usfda-observations-124052000135_1.html